E1	Age:T1 Eq-Comparison:E2
E2	Eq-Comparison:T2 Operator:T83 Value:T84 Temporal-Unit:T85
E3	Observation:T3 Name:T86 Eq-Comparison:E4
E4	Eq-Comparison:T4 Value:T87 Operator:T88
E5	Condition:T5 Name:T90
E6	Condition:T6 Name:T91 Polarity:T94
E7	Or:T7 Arg:E6 Arg2:E8
E8	Condition:T8 Name:T92 Polarity:T93
E9	Eq-Comparison:T9 Unit:T95 Value:T96
E11	Or:T11 Arg:E10 Arg2:E12
E12	Modifier:T12 Modifies:T97
E13	Condition:T13 Name:T97 Stage:E9
E14	Modifier:T14 Modifies:T99
E15	Or:T15 Arg:E14 Arg2:E16
E16	Modifier:T16 Modifies:T99
E17	Or:T17 Arg:E84 Arg2:E85
E18	Procedure:T18 Name:T102
E19	Condition:T19 Name:T103
E20	And:T20 Arg:E87 Arg2:E21
E21	Modifier:T21 Modifies:T103
E22	Procedure:T22 Name:T139
E24	Modifier:T24 Modifies:T105
E25	Procedure:T25 Name:T105
E26	Drug:T26 Name:T106
E27	Negation:T27 Negates:E28
E30	Procedure:T30 Name:T108
E31	And:T31 Arg:E89 Arg2:E29
E32	Temporal-Connection:T32 Arg:E30 Arg2:E33
E33	Eq-Comparison:T33 Temporal-Recency:T107
E34	Procedure:T34 Name:T109 Temporality:E33
E35	And:T35 Arg:T110 Arg2:E36
E36	Condition:T36 Name:T111
E37	Or:T37 Arg:E36 Arg2:T112
E38	Procedure:T38 Name:T113 Polarity:T140
E39	Temporal-Connection:T39 Arg:E40
E40	Study:T40
E42	Modifier:T42 Modifies:T114
E43	Condition:T43 Name:T114 Temporality:E41
E44	Condition:T44 Name:T115 Stage:E92
E45	Eq-Comparison:T45 Temporal-Period:T116
E46	Procedure:T46 Name:T117 Temporality:E45
E47	Modifier:T47 Modifies:T117
E48	Or:T48 Arg:E47 Arg2:E49
E49	Modifier:T49 Modifies:T117
E52	Condition:T52 Name:T118 Minimum-Count:E50
E53	Assertion:T53 Asserted:E54
E54	Procedure:T54
E55	Temporal-Connection:T55 Arg:E54 Arg2:E56
E56	Study:T56
E58	Or:T58 Arg:E56 Arg2:E57
E59	Risk:T59 Risk-For:E62 Severity:T120
E60	Modifier:T60 Modifies:T121
E61	Or:T61 Arg:E60 Arg2:E62
E62	Condition:T62 Name:T121
E63	Encounter:T63
E64	Condition:T64 Name:T124 Severity:T123
E65	Or:T65 Arg:E64 Arg2:E66
E66	Condition:T66
E67	And:T67 Arg:E66 Arg2:E68
E68	Observation:T68 Name:T125 Eq-Comparison:E69
E69	Eq-Comparison:T69 Operator:T126 Value:T127 Temporal-Unit:T128
E70	Study:T70 Study-Of:E71
E71	Procedure:T71
E74	Procedure:T74 Name:T130
E75	Condition:T75 Name:T131
E76	Or:T76 Arg:E75 Arg2:E77
E77	Condition:T77 Name:T132
E78	Negation:T78 Negates:E79
E79	Assertion:T79 Asserted:E80
E80	Risk:T80
E81	Study:T81
E82	Condition:T82 Name:T135
E51	Modifier:T51 Modifies:T92
E83	Modifier:T136 Modifies:T91
E10	Modifier:T10 Modifies:T97
E84	Condition:T98 Name:T99
E85	Negation:T100 Negates:E18
E86	Assertion:T101 Asserted:E85
E87	Modifier:T137 Modifies:T103
E88	Assertion:T138 Asserted:E22
E23	Assertion:T23 Asserted:E25
E28	Contraindication:T28 Contraindicates:E25
E29	Modifier:T29 Modifies:T108
E89	Modifier:T104 Modifies:T108
E90	Condition:T141 Name:T142
E91	And:T143 Arg:T112 Arg2:E90
E41	Eq-Comparison:T41 Temporal-Period:T144
E92	Eq-Comparison:T145 Unit:T146 Value:T147
E50	Eq-Comparison:T50 Value:T148
E57	Encounter:T57
E93	Temporal-Connection:T119 Arg:E62 Arg2:E63
E94	Other:T122 Is-Other:E70
E95	Condition:T149 Name:T129
E72	Contraindication:T72 Contraindicates:E74
T1	Age 30 28	Age
T2	Eq-Comparison 53 49	older than 18 years
T3	Observation 69 64	ECOG
T4	Eq-Comparison 95 87	0-
T5	Condition 130 119	HNSCC
T6	Condition 139 128	HPV
T7	Or 158 147	or
T8	Condition 162 151	HPV
T9	Eq-Comparison 193 182	Stage III
T11	Or 202 190	or
T12	Modifier 206 194	IVB
T13	Condition 212 200	HNSCC
T14	Modifier 288 276	irresectable
T15	Or 291 279	or
T16	Modifier 310 298	inoperable
T17	Or 313 301	or
T18	Procedure 337 325	surgery
T19	Condition 348 336	Tumor
T20	And 362 350	and
T21	Modifier 375 363	localization
T22	Procedure 406 394	radiochemotherapy
T24	Modifier 454 442	Simultaneous standard
T25	Procedure 467 455	chemotherapy
T26	Drug 482 470	cisplatin
T27	Negation 498 485	no
T30	Procedure 534 517	Dental
T31	And 550 533	and
T32	Temporal-Connection 569 551	before
T33	Eq-Comparison 575 557	start
T34	Procedure 586 568	therapy
T35	And 606 588	with
T36	Condition 629 611	childbearing potential
T37	Or 633 615	and
T38	Procedure 681 663	contraception
T39	Temporal-Connection 839 818	before
T40	Study 862 841	trial
T42	Modifier 967 942	distant
T43	Condition 978 953	metastases
T44	Condition 985 959	UICC
T45	Eq-Comparison 1012 984	Previous
T46	Procedure 1025 997	radiotherapy
T47	Modifier 1037 1009	head
T48	Or 1041 1013	and
T49	Modifier 1046 1018	neck
T52	Condition 1076 1048	malignancy
T53	Assertion 1094 1066	likely to
T54	Procedure 1112 1084	treatment
T55	Temporal-Connection 1119 1091	during
T56	Study 1142 1114	trial intervention
T58	Or 1145 1117	or
T59	Risk 1232 1200	risk
T60	Modifier 1246 1214	recurrence
T61	Or 1249 1217	or
T62	Condition 1260 1228	metastases
T63	Encounter 1283 1249	follow-up
T64	Condition 1311 1277	disease
T65	Or 1314 1280	or
T66	Condition 1332 1298	medical condition
T67	And 1337 1303	with
T68	Observation 1353 1319	life expectancy
T69	Eq-Comparison 1375 1341	less than one year
T70	Study 1428 1394	interventional trial
T71	Procedure 1448 1414	treatment
T74	Procedure 1505 1471	radiochemotherapy
T75	Condition 1519 1485	Pregnant
T76	Or 1522 1488	or
T77	Condition 1532 1498	lactating
T78	Negation 1556 1522	not
T79	Assertion 1564 1530	able to
T80	Risk 1617 1583	consequences
T81	Study 1630 1596	trial
T82	Condition 1661 1627	Nasopharyngeal Carcinomas
T83	Eq-Operator 43 40	older than
T84	Eq-Value 47 43	18
T85	Eq-Temporal-Unit 53 49	years
T86	Observation-Name 69 64	ECOG
T87	Eq-Value 93 86	0
T88	Eq-Operator 95 87	-
T89	Eq-Value 98 88	2
T90	Condition-Name 130 119	HNSCC
T91	Condition-Name 139 128	HPV
T92	Condition-Name 162 151	HPV
T93	Polarity 171 160	positive
T95	Eq-Unit 189 178	Stage
T96	Eq-Value 193 182	III
T99	Condition-Name 261 249	Tumor
T102	Procedure-Name 337 325	surgery
T103	Condition-Name 348 336	Tumor
T105	Procedure-Name 467 455	chemotherapy
T106	Drug-Name 482 470	cisplatin
T108	Procedure-Name 534 517	Dental
T109	Procedure-Name 586 568	therapy
T110	Life-Stage-And-Gender 601 583	women
T111	Condition-Name 629 611	childbearing potential
T112	Life-Stage-And-Gender 637 619	men
T113	Procedure-Name 681 663	contraception
T114	Condition-Name 978 953	metastases
T115	Condition-Name 985 959	UICC
T116	Eq-Temporal-Period 1012 984	Previous
T117	Procedure-Name 1025 997	radiotherapy
T118	Condition-Name 1076 1048	malignancy
T120	Severity 1227 1195	considerable
T121	Condition-Name 1260 1228	metastases
T123	Severity 1303 1269	Serious
T124	Condition-Name 1311 1277	disease
T125	Observation-Name 1353 1319	life expectancy
T126	Eq-Operator 1366 1332	less than
T127	Eq-Value 1370 1336	one
T128	Eq-Temporal-Unit 1375 1341	year
T129	Condition-Name 1438 1404	cancer
T130	Procedure-Name 1505 1471	radiochemotherapy
T131	Condition-Name 1519 1485	Pregnant
T132	Condition-Name 1532 1498	lactating
T133	Life-Stage-And-Gender 1538 1504	women
T135	Condition-Name 1661 1627	Nasopharyngeal Carcinomas
T51	Modifier 178 167	tumors
T94	Polarity 148 137	negative
T136	Modifier 155 144	tumors
T10	Modifier 199 187	IVA
T97	Condition-Name 212 200	HNSCC
T98	Condition 261 249	Tumor
T100	Negation 329 317	refused
T101	Assertion 329 317	refused
T137	Modifier 358 346	extension
T138	Assertion 388 376	suitable for
T139	Procedure-Name 406 394	radiochemotherapy
T23	Assertion 493 481	applicable
T28	Contraindication 519 504	contra-indications
T29	Modifier 562 544	treatment
T104	Modifier 546 529	examination
T107	Eq-Temporal-Recency 575 557	start
T140	Polarity 667 649	adequate
T141	Condition 658 640	reproductive ages
T142	Condition-Name 658 640	reproductive ages
T143	And 640 622	in
T41	Eq-Comparison 956 931	Presence
T144	Eq-Temporal-Period 956 931	Presence
T145	Eq-Comparison 995 969	stage IVC
T146	Eq-Unit 991 965	stage
T147	Eq-Value 995 969	IVC
T50	Eq-Comparison 1065 1037	Second
T148	Eq-Value 1065 1037	Second
T57	Encounter 1157 1127	follow-up
T119	Temporal-Connection 1267 1235	within
T122	Other 1407 1373	competing
T149	Condition 1438 1404	cancer
T72	Contraindication 1483 1449	not suitable
A1	Temporal-Connection-Type-Value E32 before
A2	Temporal-Connection-Type-Value E39 before
A3	Assertion-Type-Value E53 hypothetical
A4	Temporal-Connection-Type-Value E55 during
A6	Assertion-Type-Value E79 hypothetical
A7	Eq-Operator-Value T83 GT
A8	Eq-Temporal-Unit-Value T85 year
A9	Eq-Operator-Value T88 BETWEEN
A10	Polarity-Value T93 positive
A11	Life-Stage-And-Gender-Type T110 female
A12	Life-Stage-And-Gender-Type T112 male
A13	Eq-Temporal-Period-Value T116 past
A14	Severity-Value T120 severe
A16	Severity-Value T123 severe
A17	Eq-Operator-Value T126 LT
A18	Eq-Temporal-Unit-Value T128 year
A19	Life-Stage-And-Gender-Type T133 female
A20	Polarity-Value T94 negative
A21	Assertion-Type-Value E86 hypothetical
A22	Assertion-Type-Value E88 hypothetical
A23	Assertion-Type-Value E23 hypothetical
A24	Eq-Temporal-Recency-Value T107 first-time
A25	Polarity-Value T140 normal
A26	Eq-Temporal-Period-Value T144 present
A15	Temporal-Connection-Type-Value E93 during
R1	Treatment-For Arg1:E22 Arg2:E19
R2	Using Arg1:E25 Arg2:E26
R3	Equivalent-To Arg1:E44 Arg2:E43
R4	Treatment-For Arg1:E54 Arg2:E52
R5	Caused-By Arg1:E59 Arg2:E52
R6	Treatment-For Arg1:E71 Arg2:E95
R7	If-Then Arg1:T133 Arg2:E77
R8	Caused-By Arg1:E80 Arg2:E81